Conventional and Threshold-Tracking Transcranial Magnetic Stimulation Tests for Single-handed Operation
August 16th, 2021
6.6K views
We present a suite of standardized single- and paired-pulse transcranial magnetic stimulation (TMS) recording protocols, with options for conventional amplitude measurements and threshold-tracking. This program can control three different types of magnetic stimulators and is designed to enable all tests to be performed conveniently by a single operator.
Overview
This study presents standardized protocols for single- and paired-pulse transcranial magnetic stimulation (TMS) recordings designed for ease of use by a single operator. These protocols enable automated control of three types of magnetic stimulators, facilitating robust comparison between conventional amplitude measurements and threshold-tracking techniques.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Clinical Neurophysiology
Background
- Transcranial magnetic stimulation (TMS) is a widely used technique for assessing brain function.
- Existing methods can be complex and less accessible for clinical use.
- Automating the recording process is critical for streamlining clinical assessments.
Purpose of Study
- To develop automated protocols for TMS that improve usability and standardization.
- To facilitate easier comparisons of physiological responses between different measurement techniques.
- To provide a tool for high-quality recordings in clinical settings.
Methods Used
- The study utilized standardized TMS protocols.
- Protocols include a focus on recording muscle responses through appropriate electrode placements.
- Automated systems were implemented to manage data recording and analysis methodologies.
- Steps include assessing patient history and determining muscle activation levels.
- Various TMS stimulation techniques were employed, allowing efficient data collection and analysis.
Main Results
- The study demonstrated the efficacy of automated TMS protocols in recording and analyzing muscle evoked potential responses.
- These protocols enabled consistent determination of resting motor thresholds and facilitated sophisticated analysis of paired-pulse TMS effects.
- Findings highlighted the potential for efficient, reliable clinical assessments.
Conclusions
- This study establishes a framework for automating TMS recording protocols that enhances usability in clinical practice.
- The ability to compare threshold tracking and conventional amplitude measures signifies advancements in neurophysiological assessment tools.
- Implications include improved understanding and application of TMS in both research and clinical settings.
Frequently Asked Questions
What are the advantages of the automated TMS protocols?
The automated TMS protocols are designed to be user-friendly and reduce the complexity involved in traditional methods, enhancing efficiency in clinical settings.
How is the main biological model implemented in this study?
The study focuses on utilizing TMS to record muscle responses, assessing muscle activation through proper electrode placement on targeted muscles.
What types of data does the TMS technique provide?
TMS techniques yield data on muscle evoked potentials and allow evaluations of excitability and motor thresholds, facilitating clinical assessments.
How can these protocols be applied in clinical practice?
The automated nature of the protocols allows for rapid implementation in clinical assessments, aiding practitioners in evaluating brain function effectively.
Are there any limitations to the automated TMS protocols?
While the automated protocols streamline processes, careful assessment of subject history is crucial to ensure safety and efficacy during TMS procedures.
What steps are involved in preparing for TMS?
Preparation includes assessing subject medical history, explaining the procedure, obtaining consent, and positioning electrodes appropriately for accurate TMS recordings.
Executive Industry Relevance
Automated transcranial magnetic stimulation (TMS) protocols enable single-operator execution of standardized neurophysiological assessments, supporting biomarker discovery in neurodegenerative diseases. The integration of threshold-tracking and conventional amplitude measurements provides a comparative framework for de-risking target validation in CNS drug development. This approach enhances reproducibility and scalability for early discovery workflows focused on corticospinal excitability and intracortical network modulation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by quantifying corticospinal excitability and intracortical inhibitory/facilitatory networks via SICI, LICI, SICF, and SAI/LAI protocols.
- Operational Value: Enables direct comparison between threshold-tracking and conventional TMS measurements, reducing methodological variability in target engagement assays.
- Predictive Value: Supports biomarker identification for neurodegenerative diseases like ALS, aiding in patient stratification and mechanistic de-risking.
Screening & Assay Development
- Scientific Value: Provides quantitative, automated readouts of motor-evoked potential (MEP) amplitude and silent periods for consistent assay standardization.
- Operational Value: Facilitates high-throughput, single-operator recording across three stimulator types, improving assay reproducibility and reducing technical variability.
- Predictive Value: Enables reliable compound screening by stabilizing physiological readouts through automated gating and hotspot tracking.
Translational & Preclinical Research
- Scientific Value: Bridges discovery and preclinical validation by offering disease-relevant biomarkers (e.g., threshold-tracking SICI in ALS) for target confirmation.
- Operational Value: Supports longitudinal monitoring in preclinical models through automated, repeatable TMS protocols.
- Predictive Value: Enhances translational continuity by enabling cross-species comparison of corticospinal circuit function.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing standardized, automated assessment of corticospinal excitability and intracortical networks, supporting lead identification through mechanistic de-risking.
- Discovery Biology: Enables hypothesis testing of pathway modulation via quantitative TMS readouts (e.g., MEP size, silent periods) in target validation cascades.
- Screening: Delivers assay-ready, reproducible physiological outputs with automated stimulus intensity tracking and gating for motion artifact reduction.
- Analytics: Generates MEM and MEF files with 90% confidence interval comparisons, enabling statistical evaluation of physiological responses across conditions.
- Translational Research: Aligns with biomarker-driven advancement by providing threshold-tracking SICI data linked to neurodegenerative disease phenotypes.
- Enterprise Reuse: Establishes a scalable, semi-automated platform for cross-project neurophysiological assessment, reducing dependency on specialized operators.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing biological noise through automated, standardized TMS recordings.
- Operational Value: Ensures reproducibility and scalability via single-operator control, automated analysis, and compatibility with multiple stimulator systems.
- Strategic Value: Improves go/no-go decisions by delivering quantitative, threshold-tracking biomarkers that de-risk CNS target hypotheses early.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on consistent neurophysiological profiling in healthy and disease models.
Implementation Considerations
- Requires expertise in clinical neurophysiology and TMS safety screening (e.g., epilepsy, implants).
- Depends on magnetic stimulator control infrastructure and EMG amplification systems for FDI muscle recording.
- Necessitates cross-team standardization of coil positioning, hotspot tracking, and interstimulus interval selection.
- Involves adaptation considerations for different subject populations (e.g., neurodegenerative patients) and muscle targets.
- Limited by subject discomfort during prolonged stimulation and the need for consistent relaxation to enable gating function efficacy.
Biopharma FAQs
Why does threshold-tracking TMS matter for target validation?
Threshold-tracking TMS enables direct comparison with conventional amplitude measurements by stabilizing stimulus intensity for a target MEP amplitude, reducing variability in corticospinal excitability assessments. This supports more reliable target engagement readouts in early discovery.
How does isolating the independent variable (stimulus intensity) improve discovery pipeline consistency?
By tracking stimulus intensity to maintain a constant MEP amplitude (e.g., 200 or 1000 microvolts), the protocol isolates physiological changes from stimulation fluctuations, improving assay reproducibility across runs and operators.
What quantitative dependent variable measurements enable target de-risking?
The protocol quantifies motor-evoked potential (MEP) amplitude, cortical silent period, and paired-pulse metrics (e.g., SICI, LICI) as dependent variables, providing objective measures of intracortical inhibition and facilitation for mechanistic insight.
Why do replication requirements matter for cross-functional collaboration?
Automated protocols ensure consistent replication of single- and paired-pulse TMS measures (e.g., RMT, SICI) across sessions, enabling reliable data sharing between discovery, preclinical, and clinical teams.
What statistical analysis capabilities are required before implementing threshold-tracking TMS?
Implementation requires the ability to compare individual MEM files against group controls using 90% confidence intervals, standard deviations, or standard errors, enabling statistical evaluation of physiological responses in target validation workflows.
Chapters in this video
0:05
Introduction
0:57
Preparation of the Subject for the Transcranial Magnetic Stimulation (TMS) Test
2:16
Transcranial Magnetic Stimulation (TMS) Recording
5:56
Transcranial Magnetic Stimulation (TMS) Analyses
6:49
Results: TMS Test Analysis of a Healthy Subject
7:30
Conclusion
